chap 49: Men as patients Flashcards Preview

Advanced Pharm > chap 49: Men as patients > Flashcards

Flashcards in chap 49: Men as patients Deck (10)
Loading flashcards...
1
Q
  1. The factor that has the greatest effect on males developing male sexual characteristics is:
  2. Cultural beliefs
  3. Effective male role models
  4. Adequate intake of testosterone in the diet
  5. Androgen production
A

4.

Androgen production

2
Q
  1. When assessing a male for hypogonadism prior to prescribing testosterone replacement, serum testosterone levels are drawn:
  2. Without regard to time of day
  3. First thing in the morning
  4. Late afternoon
  5. In the evening
A
  1. First thing in the morning
3
Q
  1. Some research supports that testosterone replacement therapy may be indicated in which of the following diagnoses in men?
  2. Age-related decrease in cognitive functioning
  3. Metabolic syndrome
  4. Decreased muscle mass in aging men
  5. All of the above
A
  1. All of the above
4
Q
  1. The goal of testosterone replacement therapy is:
  2. Absence of all hypogonadism symptoms
  3. Testosterone levels in the mid-normal range 1 week after an injection
  4. Testosterone levels in the mid-normal range just prior to the next injection
  5. Avoidance of high serum testosterone levels during therapy
A
  1. Testosterone levels in the mid-normal range 1 week after an injection
5
Q
  1. While on testosterone replacement, hemoglobin and hematocrit levels should be monitored. Levels suggestive of excessive erythrocytosis or abuse are:
  2. Hemoglobin 14 g/dl or hematocrit 39%
  3. Hemoglobin 11.5 g/dl or hematocrit 31%
  4. Hemoglobin 13 g/dl or hematocrit 38%
  5. Hemoglobin 17.5 g/dl or hematocrit 54%
A
  1. Hemoglobin 17.5 g/dl or hematocrit 54%
6
Q
  1. Monitoring of an older male patient on testosterone replacement includes:
  2. Oxygen saturation levels at every visit
  3. Serum cholesterol and lipid profile every 3 to 6 months
  4. Digital rectal prostate screening exam at 3 and 6 months after starting therapy
  5. Bone mineral density at 3 months and 6 months after starting therapy
A
  1. Digital rectal prostate screening exam at 3 and 6 months after starting therapy
7
Q
  1. When prescribing phosphodiesterase type 5 (PDE-5) inhibitors such as sildenafil (Viagra) patients should be screened for use of:
  2. Statins
  3. Nitrates
  4. Insulin
  5. Opioids
A
  1. Nitrates
8
Q
  1. Men who are prescribed phosphodiesterase type 5 (PDE-5) inhibitors for erectile dysfunction should be educated regarding the adverse effects of the drug which include:
  2. Hearing loss
  3. Hypotension
  4. Delayed ejaculation
  5. Dizziness
A
  1. Hearing loss
9
Q
  1. Male patients who should not be prescribed phosphodiesterase type 5 (PDE-5) inhibitors include:
  2. Diabetics
  3. Those who have had an acute myocardial infarction in the past 6 months
  4. Patients who are deaf
  5. Patients under age 60 years of age
A
  1. Those who have had an acute myocardial infarction in the past 6 months
10
Q
  1. Monitoring of male patients who are using phosphodiesterase type 5 (PDE-5) inhibitors includes:
  2. Serum fasting glucose levels
  3. Cholesterol and lipid levels
  4. Blood pressure
  5. Complete blood count
A
  1. Blood pressure

Decks in Advanced Pharm Class (53):